Literature DB >> 17668454

Search for new antagonist ligands for adenosine receptors from QSAR point of view. How close are we?

Maykel Pérez González1, Carmen Terán, Marta Teijeira.   

Abstract

In view of the large libraries of nucleoside analogues that are now being handled in organic synthesis, the identification of drug biological activity is advisable prior to synthesis and this can be achieved by employing predictive biological property methods. In this sense, Quantitative Structure-Activity Relationships (QSAR) or docking approaches have emerged as promising tools. Although a large number of in silico approaches have been described in the literature for the prediction of different biological activities, the use of QSAR applications to develop adenosine receptor (AR) antagonists is not common as for the case of the antibiotics and anticancer compounds for instance. The intention of this review is to summarize the present knowledge concerning computational predictions of new molecules as adenosine receptor antagonists. Copyright (c) 2007 Wiley-Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17668454     DOI: 10.1002/med.20108

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  1 in total

1.  Design, synthesis and biological evaluation of bivalent ligands against A(1)-D(1) receptor heteromers.

Authors:  Jian Shen; Lei Zhang; Wan-ling Song; Tao Meng; Xin Wang; Lin Chen; Lin-yin Feng; Ye-chun Xu; Jing-kang Shen
Journal:  Acta Pharmacol Sin       Date:  2013-01-21       Impact factor: 6.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.